secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001213900-23-096536
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oramed appoints Dr. Daniel Aghion to board of directors effective Jan 1, 2024
-----------------------------------------------------------------------------

- Board size increased by one; Dr. Aghion fills resulting vacancy effective January 1, 2024.
- Aghion is a neurosurgeon at Memorial Neuroscience Institute since 2016.
- Compensation will match fees paid to other non-executive directors.
- No arrangements or transactions requiring disclosure under Item 404(a) in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023096536/0001213900-23-096536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023096536/ea190226-8k_oramedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-096536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer